Table 1.
Total Sample (N = 489) |
FRESH START Intervention (n = 236) |
Attention Control (n = 253) |
|||||||
---|---|---|---|---|---|---|---|---|---|
Characteristic | No. of participants |
% | No. of participants |
% | No. of participants |
% | |||
Age, years | |||||||||
Mean | 57.2 | 57.4 | 57.1 | ||||||
SD | 10.7 | 10.1 | 11.2 | ||||||
Range | 22–85 | 30–78 | 22–85 | ||||||
Race | |||||||||
White | 413 | 85 | 200 | 85 | 213 | 84 | |||
Black | 59 | 12 | 25 | 11 | 34 | 13 | |||
Other | 17 | 4 | 11 | 5 | 6 | 2 | |||
Source of ascertainment | |||||||||
Self-referral | 185 | 38 | 90 | 38 | 95 | 38 | |||
Cancer registry | 304 | 62 | 146 | 62 | 158 | 63 | |||
Type and clinical stage of cancer | |||||||||
Breast | |||||||||
Stage 0 | 39 | 14 | 18 | 13 | 21 | 15 | |||
Stage I | 148 | 53 | 78 | 57 | 70 | 50 | |||
Stage II | 78 | 28 | 33 | 24 | 45 | 32 | |||
Stage III | 13 | 5 | 8 | 6 | 5 | 4 | |||
Prostate | |||||||||
Stage I | 83 | 39 | 41 | 41 | 42 | 38 | |||
Stage II | 111 | 53 | 51 | 52 | 60 | 54 | |||
Unknown | 17 | 8 | 7 | 7 | 10 | 9 | |||
Treatment | |||||||||
Surgery | 416 | 85 | 206 | 87 | 210 | 83 | |||
Radiation therapy | 221 | 45 | 108 | 46 | 113 | 45 | |||
Chemotherapy | 127 | 26 | 64 | 27 | 63 | 25 | |||
Hormonal therapy | 195 | 40 | 99 | 42 | 96 | 38 | |||
Other | 17 | 4 | 7 | 3 | 10 | 4 | |||
No. of comorbid conditions | |||||||||
Mean | 2.1 | 2.0 | 2.2 | ||||||
SD | 1.7 | 1.8 | 1.7 | ||||||
Range | 0–11 | 0–10 | 0–11 | ||||||
Education | |||||||||
≤ High school graduate | 56 | 11 | 28 | 12 | 28 | 11 | |||
Some college or associate | 145 | 30 | 64 | 27 | 81 | 32 | |||
College graduate/postgraduate | 288 | 59 | 144 | 61 | 144 | 57 |